hygromycin b has been researched along with African Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cavacini, L; Estabrooks, A; Franken, M; Scadden, DT; Sherburne, B; Wang, F | 1 |
| Fujiwara, S; Ji, Z; Shimizu, N; Takada, K; Tanabe-Tochikura, A | 1 |
2 other study(ies) available for hygromycin b and African Lymphoma
| Article | Year |
|---|---|
Epstein-Barr virus-driven gene therapy for EBV-related lymphomas.
Topics: Animals; Antimetabolites; Burkitt Lymphoma; Cinnamates; Epstein-Barr Virus Nuclear Antigens; Ganciclovir; Genetic Therapy; Herpesvirus 4, Human; Humans; Hygromycin B; Mice; Mice, SCID; Neoplasm Transplantation; Promoter Regions, Genetic; Recombinant Fusion Proteins; Simplexvirus; Thymidine Kinase; Transcription Factors; Tumor Cells, Cultured | 1996 |
Partial elimination of Epstein-Barr virus plasmids from Burkitt's lymphoma cells by transfecting the BZLF1 gene.
Topics: Antigens, Viral; Burkitt Lymphoma; Drug Resistance; Epstein-Barr Virus Nuclear Antigens; Herpesvirus 4, Human; Humans; Hygromycin B; Plasmids; Selection, Genetic; Transfection; Tumor Cells, Cultured; Virus Replication | 1992 |